ACB
$1.430 (1.42%)
ACNNF
$0.030 (0%)
AERO
$3.210 (0%)
ALEAF
$0.050 (-14.97%)
AMMJ
$0.048 (12.81%)
APHA
$15.380 (0%)
ARNA
$99.990 (0%)
ATT:CNX
$0.080 (0%)
AUSA:CNX
$0.065 (0%)
AUSAF
$0.050 (0%)
AVXL
$11.060 (-0.98%)
BAMM:CNX
$0.130 (0%)
BBM:CNX
$0.030 (-14.29%)
BBRRF
$0.027 (-3.27%)
BE:CNX
$0.005 (0%)
BIO:CNX
$0.013 (0%)
BLIS:CNX
$0.315 (0%)
BLO:CNX
$0.395 (2.6%)
BLOZF
$0.308 (2.5%)
BUDZ
$0.100 (-9.09%)
CADMF
$0.052 (0%)
CALI:CNX
$0.085 (13.33%)
CANN
$0.230 (-2.13%)
CARA
$9.060 (-6.69%)
CBWTF
$0.062 (0.16%)
CGC
$2.540 (-0.97%)
CGRW
$0.016 (-22%)
CHOO:CNX
$0.005 (0%)
CHOOF
$0.003 (-16%)
CNBX
$3.990 (0%)
CNGGF
$0.203 (0%)
CODI
$22.680 (0.22%)
CPMD
$0.020 (-4.81%)
CRBP
$0.281 (0.07%)
CRON
$3.050 (0.33%)
CROP:CNX
$0.015 (0%)
CSI:CNX
$0.070 (-12.5%)
CURR
$0.349 (2.65%)
CVSI
$0.033 (7.49%)
DIGP
$0.014 (0%)
EEVVF
$0.078 (0%)
EMHTF
$0.039 (10.17%)
EPWCF
$0.059 (0%)
FFT:CNX
$0.040 (0%)
FNNZF
$0.075 (13.64%)
GNBT
$0.001 (0%)
GRIN:CNX
$0.075 (-16.67%)
GRWG
$4.840 (-1.83%)
GTBIF
$10.150 (-1.46%)
GTII:CNX
$13.090 (-1.65%)
GWPH
$218.960 (0%)
HEXO
$0.196 (-0.56%)
HHPHF
$0.079 (0%)
HLSPY
$0.363 (0%)
HMLSF
$2.800 (0%)
HMPPF
$0.498 (0%)
HRVOF
$0.023 (-11.07%)
HSTRF
$0.135 (0%)
HUGE:CNX
$1.180 (-1.67%)
IAN:CNX
$0.075 (0%)
IGC
$0.520 (-3.02%)
IGXT
$0.219 (13.76%)
IIPR
$92.910 (-2.5%)
INQD
$0.009 (-3.23%)
IONC:CNX
$0.005 (0%)
IONKF
$0.005 (-2.04%)
ISOL:CNX
$0.035 (0%)
ITHUF
$0.062 (5.65%)
KBEV:CNX
$0.045 (0%)
KHRNF
$0.091 (-2.15%)
KSHB
$0.695 (0%)
LHS:CNX
$1.470 (0%)
LHSIF
$1.145 (0%)
LXX:CNX
$8.400 (0%)
MCIG
$0.028 (0%)
MEDIF
$0.057 (1.15%)
MGWFF
$0.060 (9.57%)
MJ:CNX
$0.050 (0%)
MJNA
$0.015 (1.4%)
MNTR
$0.040 (0%)
MYM:CNX
$0.140 (0%)
MYMMF
$0.106 (0%)
NCNNF
$0.058 (0%)
NDVAF
$0.111 (-6.17%)
NGW:CNX
$0.410 (0%)
NRXCF
$0.035 (0%)
NSPDF
$0.010 (-23.53%)
NVTQF
$0.596 (0%)
NWKRF
$0.424 (0%)
NXGWF
$0.316 (0%)
NXTTF
$0.033 (6.61%)
OH:CNX
$5.330 (0%)
ORHOF
$4.050 (0%)
PHCG
$0.001 (0%)
PHVAF
$0.038 (0%)
PILL:CNX
$0.230 (-17.86%)
PKG:CNX
$0.020 (-20%)
PLPRF
$0.357 (0%)
PLUS:CNX
$0.440 (0%)
PMCB
$2.420 (0%)
PNPL
$0.012 (0%)
PTNYF
$0.018 (3.24%)
QCA:CNX
$0.095 (-5%)
RDDTF
$0.020 (1.53%)
RLLVF
$0.001 (0%)
RMHB
$0.028 (2.8%)
RQB:CNX
$0.005 (0%)
RQHTF
$0.448 (2.99%)
SLNG:CNX
$0.095 (-9.52%)
SMG
$83.180 (-1.21%)
SNN:CNX
$0.155 (0%)
SOL:CNX
$0.320 (0%)
SOLCF
$0.250 (0%)
SPLIF
$0.016 (-15.79%)
SPRWF
$0.268 (0%)
STEM:CNX
$0.035 (0%)
STMH
$0.028 (1.45%)
SUN:CNX
$0.150 (0%)
TBPMF
$0.052 (3.82%)
TCAN:CNX
$0.135 (0%)
TCNAF
$0.080 (0%)
TER:CNX
$3.480 (-0.57%)
TGEN
$1.200 (0%)
TGIF:CNX
$0.025 (-16.67%)
TGIFF
$0.020 (-12.28%)
THC:CNX
$0.048 (0%)
THCBF
$0.044 (12.85%)
TLRY
$3.540 (1.14%)
TRLFF
$0.035 (0%)
TRSSF
$2.710 (0.37%)
TURV
$0.001 (0%)
VIDA:CNX
$0.055 (0%)
VIN:CNX
$0.015 (0%)
VPRB
$0.047 (-6%)
VRTHF
$0.026 (0%)
VVCIF
$0.035 (-8.14%)
WAYL:CNX
$0.740 (0%)
XXII
$1.740 (-12.12%)
ZDPY
$0.740 (-2.63%)
ZYNE
$1.190 (-0.83%)
Oakville, Ontario--(Newsfile Corp. - March 7, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases, announced study results from one of its international…
Oakville, Ontario--(Newsfile Corp. - January 17, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases, announced today that the first patient has been enrolled in…
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has provided clearance to proceed with the Company’s Investigational New Drug (IND) application to commence a…